Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.48 |
| ▸ | MAPT | P10636 | 9/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23850866 | 0.87 | MAPT (0.53) | GAAALDH1A1MAPTCYP1A2CYP2C19 | |
| SCHEMBL21378295 | 0.79 | ALDH1A1 (0.54) | GAAALDH1A1MAPTCYP1A2CYP2C19 | |
| SCHEMBL23850805 | 0.79 | GAA (0.63) | GAAALDH1A1MAPTHTTSMN1; SMN2 | |
| SCHEMBL29036633 | 0.79 | ALDH1A1 (0.40) | GAAALDH1A1MAPTCYP1A2CYP2C19 | |
| SCHEMBL23850534 | 0.78 | ALDH1A1 (0.42) | GAAALDH1A1MAPTHTTSMN1; SMN2 | |
| SCHEMBL44889 | 0.77 | HPGD (0.58) | ALDH1A1MAPTCYP1A2CYP2C19CYP2C9 | |
| SCHEMBL1771630 | 0.76 | ALDH1A1 (0.40) | GAAALDH1A1MAPTCYP1A2CYP2C19 | |
| SCHEMBL5823781 | 0.75 | CYP1A2 (0.48) | ALDH1A1MAPTCYP1A2CYP2C19CYP2C9 | |
| SCHEMBL25983923 | 0.75 | ESPL1 (0.43) | GAAALDH1A1MAPTCYP1A2CYP2C19 | |
| SCHEMBL23850536 | 0.73 | MAPK1 (0.57) | GAAALDH1A1MAPTCYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12485169-B2 | Compounds | Grey Wolf Therapeutics Limited (GB) | 2025-12-02 | — | — | US | disclosed |
| US-20230064417-A1 | COMPOUNDS | Grey Wolf Therapeutics Limited (GB) | 2023-03-02 | — | — | US | disclosed |
| EP-3883650-A1 | COMPOUNDS | Grey Wolf Therapeutics Limited (GB) | 2021-09-29 | — | — | EP | disclosed |
| CN-113056305-A | Compound (I) | 格雷沃尔夫治疗有限公司 | 2021-06-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230064417-A1 | COMPOUNDS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HRH4, CBR3 | GAA 3530/4885ALDH1A1 2613/4885MAPT 4705/4885 |
| US-12485169-B2 | Compounds | SLC10A1, VHL, CFTR | GAA 96/4885ALDH1A1 276/4885MAPT 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.